Daphne Haim-Langford is a prominent figure in the biophysics industry, having studied for her PhD at the Technion - Israel Institute of Technology. She has a wealth of experience in the field, having held various positions such as Founder & CEO at Tarsier Pharma, BOD Member at Omnix Medical and Member of the Board of Directors at Orthospace Ltd. Additionally, she has experience in business development, having held roles at Xenia VC and VLX Ventures, Cellect Biotech and Medingo. She has also served as Co-Founder & Chairperson at Eximore Ltd. and CEO at PerAsist.